Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Biomind Labs The Next generation of |
Description | Biomind Labs | The next generation of |
Keywords | N/A |
WebSite | biomindlabs.com |
Host IP | 50.62.136.230 |
Location | United States |
Site | Rank |
US$2,073,805
Last updated: 2023-05-17 02:16:50
biomindlabs.com has Semrush global rank of 5,103,809. biomindlabs.com has an estimated worth of US$ 2,073,805, based on its estimated Ads revenue. biomindlabs.com receives approximately 239,286 unique visitors each day. Its web server is located in United States, with IP address 50.62.136.230. According to SiteAdvisor, biomindlabs.com is safe to visit. |
Purchase/Sale Value | US$2,073,805 |
Daily Ads Revenue | US$1,915 |
Monthly Ads Revenue | US$57,429 |
Yearly Ads Revenue | US$689,142 |
Daily Unique Visitors | 15,953 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
biomindlabs.com. | A | 7198 | IP: 50.62.136.230 |
biomindlabs.com. | NS | 3600 | NS Record: ns58.domaincontrol.com. |
biomindlabs.com. | NS | 3600 | NS Record: ns57.domaincontrol.com. |
biomindlabs.com. | MX | 3600 | MX Record: 0 biomindlabs-com.mail.protection.outlook.com. |
biomindlabs.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
biomindlabs.com. | TXT | 3600 | TXT Record: D9171993 |
Why Research Team News Investors Contact The next generation of pharma. Our Mission Discover the Future Biomind Labs is developing the next generation of pharmaceuticals to treat patients suffering from neurological disorders by targeting the drivers of disease. --> Research & Development We focus our research in transforming biomedical sciences knowledge into fast-acting/controlled-release novel drugs and tailored drug delivery systems targeting specific therapeutic indications that go beyond mental health conditions. Our commitment is to provide patients and the psychiatric community with novel pharmaceuticals that provide a comfortable, safe and efficient use, by developing: 01 A unique portfolio of molecules aimed at providing patients with access to affordable and modern day neuropsychiatric treatments 02 The most diversified pipeline of clinical trials targeting multiple diseases to seek fast-track approvals and breakthrough therapy designations for novel pharmaceuticals 03 |
HTTP/1.1 301 Moved Permanently Date: Sun, 27 Feb 2022 09:37:38 GMT Server: Apache Content-Security-Policy: upgrade-insecure-requests; Location: https://biomindlabs.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/2 200 content-security-policy: upgrade-insecure-requests; last-modified: Fri, 25 Feb 2022 14:02:25 GMT etag: "5b40273-a7ca-5d8d82603f46d" accept-ranges: bytes content-length: 42954 vary: Accept-Encoding content-type: text/html date: Sun, 27 Feb 2022 09:37:39 GMT server: Apache |
Domain Name: BIOMINDLABS.COM Registry Domain ID: 2569603493_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-11-01T16:32:59Z Creation Date: 2020-11-01T16:32:58Z Registry Expiry Date: 2022-11-01T16:32:58Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS57.DOMAINCONTROL.COM Name Server: NS58.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2022-02-27T10:56:50Z <<< |